{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:02:45Z","timestamp":1795093365280,"version":"4.10.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current screening algorithms for type 2 diabetes (T2D) rely on fasting plasma glucose (FPG) and\/or HbA1c. This fails to identify a sizeable subgroup of individuals in early stages of metabolic dysregulation who are at high risk for developing diabetes or cardiovascular disease. The Matsuda index, a combination of parameters derived from a fasting and postprandial insulin assay, is an early biomarker for metabolic dysregulation (i.e. insulin resistance\/compensatory hyperinsulinemia). The aim of this analysis was to compare four widely available anthropometric and biochemical markers indicative of this condition [waist-to-height ratio (WHtR), hypertriglyceridemic-waist phenotype (HTW), triglycerides-to-HDL-C ratio (TG\/HDL-C) and FPG] to the Matsuda index. This cross-sectional analysis included 2231 individuals with normal fasting glucose (NFG, n\u2009=\u20091333), impaired fasting glucose (IFG, n\u2009=\u2009599) and T2D (n\u2009=\u2009299) from an outpatient diabetes clinic in Germany and thus extended a prior analysis from our group done on the first two subgroups. We analyzed correlations of the Matsuda index with WHtR, HTW, TG\/HDL-C and FPG and their predictive accuracies by correlation and logistic regression analyses and receiver operating characteristics. In the entire group and in NFG, IFG and T2D, the best associations were observed between the Matsuda index and the WHtR (r\u2009=\u2009\u2212\u20090.458), followed by HTW phenotype (r\u2009=\u2009\u2212\u20090.438). As for prediction accuracy, WHtR was superior to HTW, TG\/HDL-C and FPG in the entire group (AUC 0.801) and NFG, IFG and T2D. A multivariable risk score for the prediction of insulin resistance was tested and demonstrated an area under the ROC curve of 0.765 for WHtR and its interaction with sex as predictor controlled by age and sex. The predictive power increased to 0.845 when FPG and TG\/HDL-C were included. Using as a comparator the Matsuda index, WHtR, compared to HTW, TG\/HDL-C and FPG, showed the best predictive value for detecting metabolic dysregulation. We conclude that WHtR, a widely available anthropometric index, could refine phenotypic screening for insulin resistance\/hyperinsulinemia. This may ameliorate early identification of individuals who are candidates for appropriate therapeutic interventions aimed at addressing the twin epidemic of metabolic and cardiovascular disease in settings where more extended testing such as insulin assays are not feasible.<\/jats:p>","DOI":"10.1038\/s41598-021-87266-z","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T10:18:05Z","timestamp":1618481885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance"],"prefix":"10.1038","volume":"11","author":[{"given":"Katharina","family":"Lechner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E. H.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"von Bibra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"issue":"10027","key":"87266_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"(NCD-RisC) NRFC","year":"2016","unstructured":"(NCD-RisC) NRFC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 44 million participants. Lancet (London, England) 387(10027), 1513\u20131530 (2016).","journal-title":"Lancet (London, England)"},{"issue":"5","key":"87266_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2337\/dc17-1962","volume":"41","author":"C Bommer","year":"2018","unstructured":"Bommer, C. et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care 41(5), 963\u2013970 (2018).","journal-title":"Diabetes Care"},{"issue":"10","key":"87266_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke, A., Casagrande, S., Geiss, L. & Cowie, C. C. Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012. JAMA 314(10), 1021\u20131029 (2015).","journal-title":"JAMA"},{"issue":"5","key":"87266_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6(5), 361\u2013369 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"87266_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1210\/jc.2014-2853","volume":"100","author":"K Faerch","year":"2015","unstructured":"Faerch, K. et al. Relationship between insulin resistance and beta-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes. J. Clin. Endocrinol. Metab. 100(2), 707\u2013716 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"87266_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00125-017-4468-z","volume":"61","author":"A Hulman","year":"2018","unstructured":"Hulman, A. et al. Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate. Diabetologia 61(1), 101\u2013107 (2018).","journal-title":"Diabetologia"},{"issue":"9","key":"87266_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S2213-8587(16)00082-6","volume":"4","author":"N Stefan","year":"2016","unstructured":"Stefan, N., Fritsche, A., Schick, F. & Haring, H. U. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol. 4(9), 789\u2013798 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"87266_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2337\/dc18-0279","volume":"41","author":"A Hulman","year":"2018","unstructured":"Hulman, A. et al. Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study. Diabetes Care 41(8), 1740\u20131748 (2018).","journal-title":"Diabetes Care"},{"issue":"7","key":"87266_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/dme.13370","volume":"34","author":"R Jagannathan","year":"2017","unstructured":"Jagannathan, R. & Bergman, M. Use of 1-h post-load plasma glucose concentration to identify individuals at high risk of developing type 2 diabetes. Diabet. Med. 34(7), 877\u2013878 (2017).","journal-title":"Diabet. Med."},{"issue":"1","key":"87266_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2337\/dc17-1351","volume":"41","author":"M Pareek","year":"2018","unstructured":"Pareek, M. et al. Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study. Diabetes Care 41(1), 171\u2013177 (2018).","journal-title":"Diabetes Care"},{"issue":"6","key":"87266_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00592-018-1105-3","volume":"55","author":"R Jagannathan","year":"2018","unstructured":"Jagannathan, R. et al. The 1-h post-load plasma glucose as a novel biomarker for diagnosing dysglycemia. Acta Diabetol. 55(6), 519\u2013529 (2018).","journal-title":"Acta Diabetol."},{"issue":"2","key":"87266_CR12","doi-asserted-by":"publisher","first-page":"e000656","DOI":"10.1136\/openhrt-2017-000656","volume":"4","author":"JJ DiNicolantonio","year":"2017","unstructured":"DiNicolantonio, J. J., Bhutani, J., Jh, O. K. & Crofts, C. Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk. Open Heart 4(2), e000656 (2017).","journal-title":"Open Heart"},{"issue":"12","key":"87266_CR13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman, G. I. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 371(12), 1131\u20131141 (2014).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"87266_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"J-P Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s, J.-P. Body fat distribution and risk of cardiovascular disease. Circulation 126(10), 1301\u20131313 (2012).","journal-title":"Circulation"},{"issue":"4","key":"87266_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/met.2019.0115","volume":"18","author":"K Lechner","year":"2020","unstructured":"Lechner, K. et al. High-risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation. Metab. Syndr. Relat. Disord. 18(4), 176\u2013185 (2020).","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"9","key":"87266_CR16","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462\u20131470 (1999).","journal-title":"Diabetes Care"},{"issue":"2","key":"87266_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1210\/jc.2014-2299","volume":"100","author":"C Lorenzo","year":"2015","unstructured":"Lorenzo, C., Haffner, S. M., Stan\u010d\u00e1kov\u00e1, A., Kuusisto, J. & Laakso, M. Fasting and OGTT-derived measures of insulin resistance as compared with the euglycemic-hyperinsulinemic clamp in Nondiabetic Finnish offspring of type 2 diabetic individuals. J. Clin. Endocrinol. Metab. 100(2), 544\u2013550 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"87266_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell, M., Gunn, P. & Gibson, S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes. Rev. 13(3), 275\u2013286 (2012).","journal-title":"Obes. Rev."},{"issue":"1","key":"87266_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3803\/EnM.2016.31.1.127","volume":"31","author":"YJ Son","year":"2016","unstructured":"Son, Y. J. et al. Association of waist-height ratio with diabetes risk: a 4-year longitudinal retrospective study. Endocrinol Metab. 31(1), 127\u2013133 (2016).","journal-title":"Endocrinol Metab."},{"issue":"3","key":"87266_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12020-019-01945-6","volume":"64","author":"CM Ma","year":"2019","unstructured":"Ma, C. M. et al. Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis. Endocrine 64(3), 469\u2013485 (2019).","journal-title":"Endocrine"},{"issue":"23","key":"87266_CR21","doi-asserted-by":"publisher","first-page":"23B","DOI":"10.1016\/S0828-282X(07)71007-3","volume":"2007","author":"IP Lemieux","year":"2007","unstructured":"Lemieux, I. P. et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?. Can J Cardiol 2007(23), 23B-31B (2007).","journal-title":"Can J Cardiol"},{"issue":"3","key":"87266_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","volume":"96","author":"T McLaughlin","year":"2005","unstructured":"McLaughlin, T. et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am. J. Cardiol. 96(3), 399\u2013404 (2005).","journal-title":"Am. J. Cardiol."},{"key":"87266_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/joim.12036","volume":"273","author":"HA Salazar","year":"2013","unstructured":"Salazar, H. A. et al. Identifying cardiovascular disease risk and outcome: use of plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J. Intern. Med. 273, 595\u2013601 (2013).","journal-title":"J. Intern. Med."},{"key":"87266_CR24","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jamacardio.2019.2261","volume":"4","author":"K Lechner","year":"2019","unstructured":"Lechner, K. & Halle, M. Are atherogenic lipoprotein phenotype and inflammation indicative of plaque phenotype and clinical stability in coronary artery disease?. JAMA Cardiol. 4, 951\u2013952 (2019).","journal-title":"JAMA Cardiol."},{"key":"87266_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jamacardio.2019.2231","volume":"4","author":"R Vergallo","year":"2019","unstructured":"Vergallo, R., Porto, I. & Crea, F. Are atherogenic lipoprotein phenotype and inflammation indicative of plaque phenotype and clinical stability in coronary artery disease?-Reply. JAMA Cardiol. 4, 951\u2013952 (2019).","journal-title":"JAMA Cardiol."},{"issue":"4","key":"87266_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamacardio.2019.0275","volume":"4","author":"R Vergallo","year":"2019","unstructured":"Vergallo, R. et al. Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: an in vivo optical coherence tomography study. JAMA Cardiol. 4(4), 321\u2013329 (2019).","journal-title":"JAMA Cardiol."},{"issue":"8","key":"87266_CR27","doi-asserted-by":"publisher","first-page":"e009126","DOI":"10.1161\/JAHA.117.008139","volume":"7","author":"S LeBlanc","year":"2018","unstructured":"LeBlanc, S. et al. Hypertriglyceridemic waist: a simple marker of high-risk atherosclerosis features associated with excess visceral adiposity\/ectopic fat. J. Am. Heart Assoc. 7(8), e009126 (2018).","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"87266_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1055\/s-0043-107782","volume":"49","author":"H von Bibra","year":"2017","unstructured":"von Bibra, H., Saha, S., Hapfelmeier, A., Muller, G. & Schwarz, P. E. H. Impact of the triglyceride\/high-density lipoprotein cholesterol ratio and the hypertriglyceremic-waist phenotype to predict the metabolic syndrome and insulin resistance. Horm. Metab. Res. 49(7), 542\u2013549 (2017).","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"87266_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2337\/diacare.26.3.868","volume":"26","author":"M Hanefeld","year":"2003","unstructured":"Hanefeld, M. et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 26(3), 868\u2013874 (2003).","journal-title":"Diabetes Care"},{"issue":"12","key":"87266_CR30","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"32","author":"F Tosi","year":"2017","unstructured":"Tosi, F., Bonora, E. & Moghetti, P. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum. Reprod. 32(12), 2515\u20132521 (2017).","journal-title":"Hum. Reprod."},{"issue":"1","key":"87266_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/2230-8210.146874","volume":"19","author":"M Gutch","year":"2015","unstructured":"Gutch, M., Kumar, S., Razi, S. M., Gupta, K. K. & Gupta, A. Assessment of insulin sensitivity\/resistance. Indian J Endocrinol Metab. 19(1), 160\u2013164 (2015).","journal-title":"Indian J Endocrinol Metab."},{"key":"87266_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nmeth.3904","volume":"13","author":"JKM Lever","year":"2016","unstructured":"Lever, J. K. M. & Altman, N. Logistic regression. Nat. Methods 13, 541\u2013542 (2016).","journal-title":"Nat. Methods"},{"issue":"4","key":"87266_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell, F. E. Jr., Lee, K. L. & Mark, D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15(4), 361\u2013387 (1996).","journal-title":"Stat. Med."},{"issue":"9833","key":"87266_CR34","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tabak","year":"2012","unstructured":"Tabak, A. G., Herder, C., Rathmann, W., Brunner, E. J. & Kivimaki, M. Prediabetes: a high-risk state for diabetes development. Lancet (London, England). 379(9833), 2279\u20132290 (2012).","journal-title":"Lancet (London, England)."},{"key":"87266_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2017.01.003","volume":"234","author":"H von Bibra","year":"2017","unstructured":"von Bibra, H., Str\u00f6hle, A., St John Sutton, M. & Worm, N. Dietary therapy in heart failure with preserved ejection fraction and\/or left ventricular diastolic dysfunction in patients with metabolic syndrome. Int. J. Cardiol. 234, 7\u201315 (2017).","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"87266_CR36","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2337\/dc13-2668","volume":"37","author":"FB Kraemer","year":"2014","unstructured":"Kraemer, F. B., Ginsberg, H. N., Gerald, M. & Reaven, M. D. Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease. Diabetes Care 37(5), 1178 (2014).","journal-title":"Diabetes Care"},{"issue":"7","key":"87266_CR37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","volume":"28","author":"M Adiels","year":"2008","unstructured":"Adiels, M., Olofsson, S. O., Taskinen, M. R. & Boren, J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28(7), 1225\u20131236 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7121","key":"87266_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despres","year":"2006","unstructured":"Despres, J. P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444(7121), 881\u2013887 (2006).","journal-title":"Nature"},{"issue":"2","key":"87266_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","volume":"16","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou, E. K. & Antoniades, C. The role of adipose tissue in cardiovascular health and disease. Nat. Rev. Cardiol. 16(2), 83\u201399 (2019).","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"87266_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/CIRCRESAHA.118.312806","volume":"123","author":"CW Chia","year":"2018","unstructured":"Chia, C. W., Egan, J. M. & Ferrucci, L. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk. Circ. Res. 123(7), 886\u2013904 (2018).","journal-title":"Circ. Res."},{"issue":"3","key":"87266_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacc.2018.04.061","volume":"72","author":"OP Ganda","year":"2018","unstructured":"Ganda, O. P., Bhatt, D. L., Mason, R. P., Miller, M. & Boden, W. E. Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J. Am. Coll. Cardiol. 72(3), 330\u2013343 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"87266_CR42","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1503\/cmaj.091276","volume":"182","author":"BJ Arsenault","year":"2010","unstructured":"Arsenault, B. J. et al. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ Can Med Assoc J 182(13), 1427\u20131432 (2010).","journal-title":"CMAJ Can Med Assoc J"},{"issue":"1","key":"87266_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2015.06.057","volume":"242","author":"R Quispe","year":"2015","unstructured":"Quispe, R. et al. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis 242(1), 243\u2013250 (2015).","journal-title":"Atherosclerosis"},{"issue":"12","key":"87266_CR44","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1001\/archinte.165.12.1395","volume":"165","author":"AE Sumner","year":"2005","unstructured":"Sumner, A. E., Finley, K. B., Genovese, D. J., Criqui, M. H. & Boston, R. C. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch. Intern. Med. 165(12), 1395\u20131400 (2005).","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"87266_CR45","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/2047487319869400","volume":"27","author":"K Lechner","year":"2020","unstructured":"Lechner, K. et al. Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors. Eur. J. Prev. Cardiol. 27(4), 394\u2013406 (2020).","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87266-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:49:55Z","timestamp":1670050195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87266-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87266-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"6 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8224"}}